Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05646160

Effects of MTRPs Therapy in Migraine.

Conditions: Migraine, Pain, Shoulder, Trapezius Muscle Strain Left, Trapezius Muscle Strain Right, Muscle Pain, Trigger Point Pain, Myofascial, Cervical Pain

Sex: Female
Ages: 18 Years – 65 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 100
Sponsor: Józef Piłsudski University of Physical Education

Location: Poland

Summary

Case series, repeated-measures design, pilot study.Adult, female, migraine patients underwent seven Ischemic Compression Myofascial Trigger Points (IC-MTrPs) therapy sessions.The aim of the study is to investigate whether therapy of the shoulder girdle and neck muscles by deactivating MTrPs causes modification of biomechanical and biochemical variables in the blood and reduces headache in people with migraine, improving their quality of life by improving their health.People qualified for the study were divided into 3 groups according to the type of migraine:CM group - patients with chronic migraineEMa group - patients with paroxysmal migraine with auraEMb group - patients with paroxysmal migraine without an aura.All patients underwent 7 interventions in the area of the muscles of the shoulder girdle and neck (by deactivating trigger points) performed every 2 or 3 days. They did not take any headache medications during the treatment period. However, during a migraine attack, they could undergo treatments and research measurements. Biomechanical measurements of the cervical spine, shoulder girdle muscles and blood chemistry were performed before, during and after the patients' therapy.All treatments were performed on the following muscles:m. trapesius pars descendent (trapezius upper),m. sternocleidomastoideus (sternocleidomastoid),m. temporalis (temporal),m. legator scapulae (levator scapula),m. supraspinatus (supraspinatus),m. suboccipitales (suboccipital).

Eligibility Criteria

Inclusion Criteria:age: 18 to 65 years of age, female gender, migraine diagnosed by a specialist neurologist for at least 12 months, no metabolic, cardiological, neurological and orthopedic diseases within the shoulder girdle, and cervical spine, voluntary written consent for examination; criteria according to ICHD-3 allowing to classify the symptoms as migraines.Exclusion Criteria:minors or over 65 years of age, male gender, patients undergoing pharmacological treatment that cannot be discontinued; people with other headaches; past injuries of the musculoskeletal system in the cervical spine and shoulder girdle; skin diseases and other conditions such as deep vein thrombosis, osteoporosis; criteria for excluding migraine according to ICHD-3.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05646160). StuddyBuddy aggregates publicly available trial information.